| 0 (0%) | 12-05 09:28 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.17 |
1-year : | 2.48 |
| Resists | First : | 1.85 |
Second : | 2.13 |
| Pivot price | 1.63 |
|||
| Supports | First : | 1.41 | Second : | 1.18 |
| MAs | MA(5) : | 1.65 |
MA(20) : | 1.63  |
| MA(100) : | 1.83 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 50.1 |
D(3) : | 67.8 |
| RSI | RSI(14): 38.4 |
|||
| 52-week | High : | 2.48 | Low : | 1.41 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ IMRN ] has closed above bottom band by 26.4%. Bollinger Bands are 10.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.62 - 1.63 | 1.63 - 1.64 |
| Low: | 1.43 - 1.44 | 1.44 - 1.45 |
| Close: | 1.55 - 1.56 | 1.56 - 1.57 |
Wed, 03 Dec 2025
Immuron Limited (IMRN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Wed, 03 Dec 2025
Immuron Limited (IMRN) Plunges Amidst Management Uncertainty and Bearish Market Sentiment - Markets Financial Content
Wed, 03 Dec 2025
IMRN Stock Faces Renewed Optimism Following Strategic Moves - StocksToTrade
Wed, 03 Dec 2025
Immuron (IMRN) Collaborates on Vaccine Research with US Military Institutes - GuruFocus
Wed, 03 Dec 2025
Immuron (NASDAQ: IMRN) adds U.S. DoD award as ETEC colostrum trial reports topline data next week - Stock Titan
Wed, 12 Nov 2025
Immuron Reports Strong FY2025 Results and Outlines FY2026 Plans - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 7 (M) |
| Shares Float | 264 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0.9 (%) |
| Shares Short | 136 (K) |
| Shares Short P.Month | 26 (K) |
| EPS | -0.59 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.02 |
| Profit Margin | -71.6 % |
| Operating Margin | -85.6 % |
| Return on Assets (ttm) | -26.1 % |
| Return on Equity (ttm) | -50.3 % |
| Qtrly Rev. Growth | 29.2 % |
| Gross Profit (p.s.) | 0.68 |
| Sales Per Share | 1.04 |
| EBITDA (p.s.) | -0.77 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -6 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | -2.65 |
| PEG Ratio | 0 |
| Price to Book value | 52 |
| Price to Sales | 1.48 |
| Price to Cash Flow | -1.77 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|